H.R. 4710 · 116th Congress

Pharmaceutical Independence Long-Term Readiness Reform Act

Stage
In committee
Introduced
2019-10-17
Latest action
2019-11-08 · Referred to the Subcommittee on Health.

Summary

Pharmaceutical Independence Long-Term Readiness Reform Act

This bill generally requires the Department of Defense (DOD) and the Department of Veterans Affairs to only purchase American-made medicines and vaccines. DOD must also (1) report to Congress on medicine supply-chain vulnerabilities, and (2) establish strategies to assure the provision of medicines to enable combat readiness and force health protection.